Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma

The long-term survival benefit of treating unresectable hepatocellular carcinoma (HCC) patients with transarterial chemoembolization (TACE) rather than conservative treatment remains controversial. This retrospective case-control study evaluated the survival of patients with unresectable HCC treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Jie-Yu, Li, Shu-Mei, Fan, Hai-Yan, Zhang, Lan, Zhao, Hui-Jin, Li, Sheng-Mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112993/
https://www.ncbi.nlm.nih.gov/pubmed/30113483
http://dx.doi.org/10.1097/MD.0000000000011872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112993/
https://www.ncbi.nlm.nih.gov/pubmed/30113483
http://dx.doi.org/10.1097/MD.0000000000011872

Ejemplares similares